クローン病（CD）治療の世界市場レポート 2024年

クローン病（CD）治療市場規模は近年力強く成長しています。2023年の111億3,000万米ドルから2024年には117億6,000万米ドルに、CAGR5.6％で拡大します。歴史的な期間の成長は、クローン病の有病率の上昇、病気に対する意識の高まり、政府の取り組み、ライフスタイルの変化に起因しています。

クローン病（CD）治療の市場規模は、今後数年間で安定した成長が見込まれます。2028年にはCAGR4.9％で142億2,000万米ドルに成長します。予測期間の成長は、併用療法の需要拡大、生物学的製剤の採用増加、クローン病（CD）治療に関する研究開発への投資に起因すると考えられます。予測期間の主な動向には、生物学的製剤の開発、革新的製品、先進診断ツール、バイオシミラーの採用などが含まれます。

クローン病（CD）治療市場の成長は、炎症性腸疾患の有病率の上昇によって促進されると予測されます。炎症性腸疾患（IBD）は、主に胃腸（GI）管に影響を及ぼす慢性炎症性疾患群です。CD治療は、慢性炎症性腸疾患を管理する人々の症状を緩和し、炎症を抑え、寛解を誘導し、全体的な生活の質を高めることを目的としています。例えば、2021年5月にBioMed Central Ltd.が行った調査では、2020年から2035年にかけて、イランで6万9000例、中東で22万例、インドで220万例、東アジアで450万例など、さまざまな地域で炎症性腸疾患の増加が予想されています。その結果、炎症性腸疾患の有病率の増加がクローン病（CD）治療市場の重要な促進要因となっています。

クローン病治療薬市場の成長が予測される背景には、臨床試験の増加があります。臨床試験は、新しい治療法の安全性と有効性を評価するために極めて重要であり、規制当局の承認やクローン病（CD）患者に対する新しい治療法の導入につながる可能性があります。より効率的なクローン病治療への需要が臨床試験を促し、患者やヘルスケアプロバイダーが副作用を抑えながら治療成績を向上させたいという願望が、研究開発の努力を促しています。例えば、カリフォルニア大学では、小児CDおよび潰瘍性大腸炎患者を対象としたvedolizumab、経口オザニモド、ミリキズマブの長期有効性に焦点を当てた17の臨床試験が進行中であると報告しています。

2023年のクローン病（CD）治療市場で最大の地域は北米でした。クローン病（CD）治療レポートがカバーしている地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のクローン病（CD）治療市場、薬剤タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 抗生物質
• アミノサリシレート
• コルチコステロイド
• 免疫調節剤
• その他
• 世界のクローン病（CD）治療市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 経口
• 注射
• 世界のクローン病（CD）治療市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院薬局
• 小売薬局
• オンライン薬局
• ドラッグストア

第7章 地域および国の分析

• 世界のクローン病（CD）治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界のクローン病（CD）治療市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• クローン病（CD）治療市場の競合情勢
• クローン病（CD）治療市場の企業プロファイル
  • Pfizer Inc.
  • Johnson and Johnson Ltd.
  • Merck and Co. Inc.
  • AbbVie Inc.
  • Novartis AG

第31章 その他の主要および革新的な企業

• Sanofi S.A.
• Bristol-Myers Squibb Company
• Abbott Laboratories
• GlaxoSmithKline Plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Amgen Inc.
• Boehringer Ingelheim International GmbH
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Bausch Health Companies Inc.
• UCB S.A.
• Sun Pharmaceutical Industries Ltd.
• Perrigo Company PLC
• Dr. Reddy's Laboratories Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

“Crohn's Disease (CD) Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on crohn's disease (cd) treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for crohn's disease (cd) treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The crohn's disease (cd) treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Drug Type: Antibiotics; Amino Salicylates; Corticosteroids; Immunomodulators; Other Drug Types
• 2) By Route of Administration: Oral; Injectable
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Drug Stores
• Companies Mentioned: Pfizer Inc.; Johnson and Johnson Ltd.; Merck and Co. Inc.; AbbVie Inc.; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Crohn's disease (CD) is an inflammatory bowel disease (IBD) that causes inflammation and swelling of the tissues in the digestive tract. Crohn's disease (CD) treatment involves various approaches, therapies, medications and interventions to manage and control the symptoms and complications of a chronic inflammatory condition.

The primary categories of drugs used in the treatment of Crohn's disease are antibiotics, aminosalicylates, corticosteroids, immunomodulators, and other types of medications. Antibiotics are drugs that combat bacterial infections by either killing the bacteria or inhibiting their growth and reproduction. These drugs can be administered orally or via injection, and they are distributed through hospital pharmacies, retail pharmacies, online pharmacies, and drug stores.

The Crohn's disease treatment market research report is one of a series of new reports from The Business Research Company that provides Crohn's disease treatment market statistics, including Crohn's disease treatment industry global market size, regional shares, competitors with a Crohn's disease treatment market share, detailed Crohn's disease treatment market segments, market trends and opportunities and any further data you may need to thrive in the Crohn's disease treatment industry. This Crohn's disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The crohn's disease (cd) treatment market size has grown strongly in recent years. It will grow from $11.13 billion in 2023 to $11.76 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to rising prevalence of crohn's disease, growing awareness of the disease, government initiatives, changing lifestyle.

The crohn's disease (cd) treatment market size is expected to see steady growth in the next few years. It will grow to $14.22 billion in 2028 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to growing demand for combination therapies, increasing adoption of biologics, investments in research and development on crohn's disease (cd) treatments. Major trends in the forecast period include development biologic drugs, innovative products, advanced diagnostic tools, biosimilars adoption.

The growth of the Crohn's disease (CD) treatment market is anticipated to be fueled by the rising prevalence of inflammatory bowel diseases. Inflammatory bowel disease (IBD) comprises a group of chronic inflammatory conditions that predominantly affect the gastrointestinal (GI) tract. CD treatment aims to alleviate symptoms, reduce inflammation, induce remission, and enhance the overall quality of life for individuals managing chronic inflammatory bowel disease. For instance, a study by BioMed Central Ltd. in May 2021 projected an expected increase in Inflammatory bowel disease cases in various regions, such as 69 thousand cases in Iran, 220 thousand cases in the Middle East, 2.2 million cases in India, and 4.5 million cases in East Asia between 2020 and 2035. As a result, the growing prevalence of inflammatory bowel diseases is a significant driver of the Crohn's disease (CD) treatment market.

Anticipated growth in the Crohn's disease treatment market can be attributed to the increasing number of clinical trials. Clinical trials are crucial for assessing the safety and effectiveness of new therapies, potentially leading to regulatory approvals and the introduction of novel treatment options for Crohn's disease (CD) patients. The demand for more efficient CD treatments encourages clinical trials, driven by the desire of patients and healthcare providers for improved outcomes with reduced side effects, thereby stimulating research and development endeavors. For example, the University of California reported 17 ongoing clinical trials focused on vedolizumab, oral ozanimod, and the long-term efficacy of mirikizumab for pediatric CD and ulcerative colitis patients, highlighting the proliferation of clinical trials in the fie

The growth of the Crohn's disease treatment market may be significantly impacted by the considerable expenses associated with treating this condition. Crohn's disease is a complex and highly variable ailment, making the development of effective treatments a challenging and costly endeavor. Creating new medications and therapies for Crohn's disease involves a complex and expensive process. As of December 2022, the initial cost of treating Crohn's disease averages around $30,000 within the first year, and individuals with inflammatory bowel disease face an annual average of $2,213 in out-of-pocket expenses, as reported by Everyday Health Inc. Consequently, the high costs of Crohn's disease treatment pose an obstacle to the expansion of the Crohn's disease (CD) treatment market.

Leading companies in the Crohn's disease (CD) treatment market are focused on the introduction of innovative technologies like IBDSENSE to maintain their market position. An example of this is the development of IBDSENSE by The IRR Chemistry Hub, an interdisciplinary hub based in Scotland. IBDSENSE is designed to enhance the diagnosis and monitoring of inflammatory bowel diseases, including Crohn's disease, through non-invasive methods. The technology utilizes fluorescence-based techniques to measure the enzyme activity of Granzyme B (GzmB) in patient biosamples, aiming to enhance the patient experience and treatment options.

In June 2023, Merck & Co. Inc., a pharmaceutical company based in the United States, completed its acquisition of Prometheus Biosciences Inc. for a total of $10.8 billion. This strategic move by Merck & Co. is intended to broaden its range of products related to the treatment of immunological and inflammatory conditions. Prometheus Biosciences, a biotechnology company based in the United States, specializes in the development of drugs for inflammatory diseases, particularly in the areas of Crohn's disease and inflammatory bowel disease treatments.

Major players in the crohn's disease (cd) treatment market are Pfizer Inc., Johnson and Johnson Ltd., Merck and Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Ferring B.V., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC .

North America was the largest region in the Crohn's disease (CD) treatment market in 2023. The regions covered in Crohn's disease (CD) treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the Crohn's disease (CD) treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The Crohn's disease (CD) treatment market consists of sales of Janus kinase inhibitors and anti-inflammatory drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Crohn's Disease (CD) Treatment Market Characteristics

3. Crohn's Disease (CD) Treatment Market Trends And Strategies

4. Crohn's Disease (CD) Treatment Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Crohn's Disease (CD) Treatment Market Size and Growth

• 5.1. Global Crohn's Disease (CD) Treatment Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Crohn's Disease (CD) Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Crohn's Disease (CD) Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Crohn's Disease (CD) Treatment Market Segmentation

• 6.1. Global Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Antibiotics
• Amino Salicylates
• Corticosteroids
• Immunomodulators
• Other Drug Types
• 6.2. Global Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Injectable
• 6.3. Global Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Drug Stores

7. Crohn's Disease (CD) Treatment Market Regional And Country Analysis

• 7.1. Global Crohn's Disease (CD) Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Crohn's Disease (CD) Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Crohn's Disease (CD) Treatment Market

• 8.1. Asia-Pacific Crohn's Disease (CD) Treatment Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Crohn's Disease (CD) Treatment Market

• 9.1. China Crohn's Disease (CD) Treatment Market Overview
• 9.2. China Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Crohn's Disease (CD) Treatment Market

• 10.1. India Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Crohn's Disease (CD) Treatment Market

• 11.1. Japan Crohn's Disease (CD) Treatment Market Overview
• 11.2. Japan Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Crohn's Disease (CD) Treatment Market

• 12.1. Australia Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Crohn's Disease (CD) Treatment Market

• 13.1. Indonesia Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Crohn's Disease (CD) Treatment Market

• 14.1. South Korea Crohn's Disease (CD) Treatment Market Overview
• 14.2. South Korea Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Crohn's Disease (CD) Treatment Market

• 15.1. Western Europe Crohn's Disease (CD) Treatment Market Overview
• 15.2. Western Europe Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Crohn's Disease (CD) Treatment Market

• 16.1. UK Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Crohn's Disease (CD) Treatment Market

• 17.1. Germany Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Crohn's Disease (CD) Treatment Market

• 18.1. France Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Crohn's Disease (CD) Treatment Market

• 19.1. Italy Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Crohn's Disease (CD) Treatment Market

• 20.1. Spain Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Crohn's Disease (CD) Treatment Market

• 21.1. Eastern Europe Crohn's Disease (CD) Treatment Market Overview
• 21.2. Eastern Europe Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Crohn's Disease (CD) Treatment Market

• 22.1. Russia Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Crohn's Disease (CD) Treatment Market

• 23.1. North America Crohn's Disease (CD) Treatment Market Overview
• 23.2. North America Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Crohn's Disease (CD) Treatment Market

• 24.1. USA Crohn's Disease (CD) Treatment Market Overview
• 24.2. USA Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Crohn's Disease (CD) Treatment Market

• 25.1. Canada Crohn's Disease (CD) Treatment Market Overview
• 25.2. Canada Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Crohn's Disease (CD) Treatment Market

• 26.1. South America Crohn's Disease (CD) Treatment Market Overview
• 26.2. South America Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Crohn's Disease (CD) Treatment Market

• 27.1. Brazil Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Crohn's Disease (CD) Treatment Market

• 28.1. Middle East Crohn's Disease (CD) Treatment Market Overview
• 28.2. Middle East Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Crohn's Disease (CD) Treatment Market

• 29.1. Africa Crohn's Disease (CD) Treatment Market Overview
• 29.2. Africa Crohn's Disease (CD) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Crohn's Disease (CD) Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Crohn's Disease (CD) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Crohn's Disease (CD) Treatment Market Competitive Landscape And Company Profiles

• 30.1. Crohn's Disease (CD) Treatment Market Competitive Landscape
• 30.2. Crohn's Disease (CD) Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson and Johnson Ltd.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Merck and Co. Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. AbbVie Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Novartis AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Crohn's Disease (CD) Treatment Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. Bristol-Myers Squibb Company
• 31.3. Abbott Laboratories
• 31.4. GlaxoSmithKline Plc
• 31.5. Takeda Pharmaceutical Company Limited
• 31.6. Eli Lilly and Company
• 31.7. Amgen Inc.
• 31.8. Boehringer Ingelheim International GmbH
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. Mylan N.V.
• 31.11. Bausch Health Companies Inc.
• 31.12. UCB S.A.
• 31.13. Sun Pharmaceutical Industries Ltd.
• 31.14. Perrigo Company PLC
• 31.15. Dr. Reddy's Laboratories Ltd.

32. Global Crohn's Disease (CD) Treatment Market Competitive Benchmarking

33. Global Crohn's Disease (CD) Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Crohn's Disease (CD) Treatment Market

35. Crohn's Disease (CD) Treatment Market Future Outlook and Potential Analysis

• 35.1 Crohn's Disease (CD) Treatment Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Crohn's Disease (CD) Treatment Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Crohn's Disease (CD) Treatment Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer